Tech Company Financing Transactions
Verily Life Sciences Funding Round
On 9/10/2022, Verily Life Sciences raised $1 billion in funding from Alphabet and private investors.
Transaction Overview
Company Name
Announced On
9/10/2022
Transaction Type
Venture Equity
Amount
$1,000,000,000
Round
Undisclosed
Investors
Alphabet (Lead Investor)
Proceeds Purpose
Verily's capital that will be used to expand its data-driven healthcare products tailored to individuals.
Company Information
Company Status
Private & Independent
Industry
Healthcare IT
Mailing Address
269 E Grand Ave.
San Francisco, CA 94080
USA
San Francisco, CA 94080
USA
Phone
Undisclosed
Website
Email Address
Overview
Verily lives at the intersection of technology, data science and healthcare. Our mission is to make the world's health data useful so that people enjoy healthier lives. Verily is developing tools to collect and organize health data, then creating interventions and platforms that put insights derived from that health data to use for more holistic care management.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Andrew Conrad
Chief Financial Officer
Deepak Ahuja
Chief Marketing Officer
Jessica Mega
Chief Operating Officer
Stephen Gillett
Chief Technical Officer
Scott Burke
Co-Founder
Brian Otis
President
Vivian Lee
VP - Bus. Development
Robert Califf
VP - Engineering
Linus Upson
VP - General Counsel
Cynthia Patton
VP - Human Resources
Sheela Krothapalli
Browse more venture capital transactions:
Prev: 9/10/2022: EnviroSpark venture capital transaction
Next: 9/11/2022: Boxabl venture capital transaction
Share this article
About Our Venture Capital Transactions Database
We do our best to report on all VC transactions involving tech companies. All VC database entries reported here are sourced from news reports and company announcements. The information comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs